BW755c, a dual lipoxygenase/cyclooxygenase inhibitor, reduces mural platelet and neutrophil deposition and vasoconstriction after angioplasty injury in pigs

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 17-21

  Provost, Patrick ^a   Merhi, Yahye ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 (3 TRIFLUOROMETHYLPHENYL) 2 PYRAZOLINE; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANGIOPLASTY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; INHIBITION KINETICS; MALE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SWINE; THROMBOCYTE AGGLUTINATION; VASOCONSTRICTION;

4,5-DIHYDRO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOL-3-AMINE; ANGIOPLASTY, BALLOON; ANIMALS; BLOOD PLATELETS; CYCLOOXYGENASE INHIBITORS; FEMALE; LIPOXYGENASE INHIBITORS; MALE; NEUTROPHILS; SUPEROXIDES; SWINE; VASOCONSTRICTION;

EID: 0030431443     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. AMSTERDAM, E. A., PAN, H. -L., RENDIG, S. V., SYMONS, J. D., FLETCHER, M. P. AND LONGHURST, J. C.: Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration. J. Am. Coll. Cardiol. 22: 1738-1744, 1993.
2. BAZZONI, G., DEJANA E. AND DEL MASCHIO, A.: Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 76: 491-499, 1991.
3. BEDNAR, M., SMITH, B., PINTO, A. AND MULLANE, K. M.: Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ. Res. 57: 131-141, 1985.
4. BELLAVITE, P., DRI, P., DELIA BIANCA, V. AND SERRA, M. C.: The measurement of superoxide anion production by granulocytes in whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity. Eur. J. Clin. Invest. 13: 363-368, 1983.
5. 4. Impact of aspirin therapy. Circulation 86: 56-63, 1992.
6. CARRY, M., KORLEY, V., WILLERSON, J. T., WEIGELT, L., FORD-HUTCHINSON, A. W. AND TAGARI, P.: Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Circulation 85: 230-236, 1992.
7. CLANCY, R. M., DAHINDEN, C. A. AND HUCLI, T. E.: Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc. Natl. Acad. Sci. U.S.A. 80: 7200-7204, 1983.
8. COĖFFIER, E., JOSEPH, D., PRÉVOST, M.-C. AND VARGAFTIG, B. B.: Platelet-leukocyte interaction: Activation of rabbit platelets by FMLP-stimulated neutrophils. Br. J. Pharmacol. 92: 393-406, 1987.
9. DE SERVI, S , MAZZONE, A., RICEVUTI, G., FIORAVANTI, A., BRAMUCCI, E., ANGOLI, L., STEFANO, G. AND SPECCHIA, G.: Granulocyte activation after coronary angioplasty in humans. Circulation 82: 140-146, 1990.
10. DEL MASCHIO, A., EVANGELISTA, V., RAJTAR, G., CHEN, Z. M., CERLETTI, C. AND DE GAETANO, G.: Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am. J. Physiol. 258: H870-H879, 1990.
11. EVANGELISTA, V., RAJTAR, G , DE GAETANO, G., WHITE, J. G. AND CERLETTI, C.: Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinases. Blood 77: 2379-2388, 1991.
12. FEINBERG, H., ROSENBAUM, D. S., LEVITSKY, S., SILVERMAN, N. A., KOHLER, J. AND LEBRETON, G.: Platelet deposition after surgically induced myocardial ischemia. An etiologic factor for reperfusion injury. J. Thorac. Cardiovasc. Surg. 84: 815-822, 1982.
13. FORD-HUTCHINSON, A. W., BRAY, M. A., DOIG, M. V., SHIPLEY, M. E. AND SMITH, M. J. H.: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (Lond.) 286: 264-265, 1980.
14. FORD-HUTCHINSON, A. AND LETTS, G.: Biological actions of leukotrienes. State of the Art Lecture. Hypertension 8:suppl. II, II-44-II-49, 1986.
15. 4 in inflammation. Immunology 10: 1-12, 1990.
16. FUSTER, V., BADIMON, L., BADIMON, J. J. AND CHESEBRO, J. H.: The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326: 310-318, 1992.
17. 2 and serotonin are possible mediators. Circulation 79: 154-166, 1989.
18. GOLINO, P., BUJA, L. M., ASHTON, J. H., KULKARNI, P., TAYLOS, A. AND WILLERSON, J. T.: Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries. Circulation 78: 701-711, 1988.
19. HANDIN, R. I., KARABIN, R. AND BOXER, G. J.: Enhancement of platelet function by superoxide anion. J. Clin. Invest. 59: 959-965, 1977.
20. HIGOS, G. A., FLOWER, R. J. AND VANE, J. R.: A new approach to anti-inflammatory drugs. Biochem. Pharmacol. 28: 1959-1961, 1979.
21. HIGGS, G. A., MUGRIDGE, K. G., MONCADA, S. AND VANE, J. R.: Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C. Proc. Natl. Acad. Sci. U.S.A. 81: 2890-2892, 1984.
22. JOLLY, S. R. AND LUCCHESI, B. R.. Effect of BW755C in an occlusion-reperfusion model of ischemic myocardial injury. Am. Heart J. 106: 8-13, 1983.
23. L-LACOSTE, L., LAM, J. Y. T., HUNG, J. AND WATERS, D.: Oral verapamil inhibits platelet thrombus formation in humans. Circulation 89: 630-634, 1994.
24. 2 receptor blockade decrease vasoconstriction but not platelet deposition after deep arterial injury (Abstract). Circulation 74:suppl. II, II-97, 1986a.
25. LAM, J. Y. T., CHESEBRO, J. H., STEELE, P. M., BADIMON, L. AND FUSTER, V.: Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 75: 243-248, 1987.
26. LAM, J. Y. T., CHESEBRO, J. H., STEELE, P. M., DEWANJEE, M. K., BADIMON, L. AND FUSTER, V.: Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J. Am. Coll. Cardiol. 8: 1380-1386, 1986b.
27. LAPETINA, E. G., REEP, B., READ, N. G. AND MONCADA, S.: Adhesion of human platelets to collagen in the presence of prostacyclin, indomethacin and compound BW 755C. Thromb. Res. 41: 325-335, 1986.
28. LAURINDO, F. R. M., DA LUZ, P. L., UINT, L., ROCHA, T. F., JAEGER, R. G. AND LOPES, E. A.: Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation 83: 1705-1715, 1991.
29. LEE, S. -L., LEVITSKY, S. AND FEINBERG, H.: Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: The inhibitory effect of aspirin. J. Pharmacol. Exp. Ther. 248: 44-49, 1989.
30. LEE, S. -L., LEVITSKY, S. AND FEINBERG, H.: Endogenous vasoconstrictor prostanoids: Role in serotonin and vasopressin-induced coronary vasoconstriction. J. Pharmacol. Exp. Ther. 258: 292-298, 1991.
31. 4. J. Biol. Chem. 263: 174-181, 1988.
32. MEHTA, P., MEHTA, J., LAWSON, D., KROP, I. AND LETTS, L. G.: Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation. Thromb. Res. 41: 731-738, 1986.
33. MERHI, Y., L-LACOSTE, L. AND LAM, J. Y. T.: Neutrophil implications in platelet deposition and vasoconstriction after deep arterial injury by angioplasty in pigs. Circulation 90: 997-1002, 1994.
34. MERHI, Y., LAM, J. Y. T., LACOSTE, L. L., LATOUR, J. -G., GUIDOIN, R. AND WATERS, D.: Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Arterioscler. Thromb. 13: 951-957, 1993
35. MERHI, Y., GUIDOIN, R., PROVOST, P., LEUNG, T. -K. AND LAM, J. Y. T.: Increase of neutrophil adhesion and vasoconstriction with platelet deposition after deep arterial injury by angioplasty. Am. Heart J. 129: 445-451, 1995.
36. MULLANE, K. M. AND MONCADA, S.: The salvage of ischaemic myocardium by BW755C in anaesthetised dogs. Prostaglandins 24: 255-266, 1982.
37. PROVOST, P., LAM, J. Y. T., LACOSTE, L., MERHI, Y. AND WATERS, D.: Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler. Thromb. 14: 331-335, 1994.
38. RANDALL, R. W., EAKINS, K. E., HIGGS, G. A., SALMON, J. A. AND TATESON, J. E.: Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Agents Actions 10: 553-555, 1980.
39. SALMON, J. A., SIMMONS, P. M. AND MONCADA, S.: The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J. Pharm. Pharmacol. 35: 808-813, 1983.